Servicios Personalizados
Revista
Articulo
Español (pdf)
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO
Links relacionados
Similares en
SciELO
Compartir
Permalink
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
versión impresa ISSN 2225-5109versión On-line ISSN 2227-4731
Resumen
VALDIVIA-TAPIA, María del Carmen; VARGAS-VEGA, Marilú Alicia; CARREAZO, NY y RAMIREZ-CORTEZ, Grimaldo de los A.. Severe rhabdomyolysis in an infant with multisystem inflammatory syndrome related to covid -19 (mis-c). Rev. Cuerpo Med. HNAAA [online]. 2022, vol.15, n.4, e1624. Epub 28-Feb-2023. ISSN 2225-5109. http://dx.doi.org/10.35434/rcmhnaaa.2022.154.1624.
Introduction:
A case of severe rhabdomyolysis associated with multisystem inflammatory syndrome related to COVID-19 (MIS-C).
Case of report:
is presented in a one-year 10-month-old boy who presented digestive symptoms, myalgia, weakness, fever, and dark urine. COVID-19 IgM (-) IgG (+) serological test, COVID-19 PCR negative. Initial creatine kinase (CK) presented non-dosable values, with the highest reported level being 517,600 U/L. The creatinine value remained normal throughout the hospitalization. He received human immunoglobulin 2 g/Kg, Methylprednisolone 10 mg/Kg/d, and acetylsalicylic acid to manage MIS-C. Aggressive hydration and urine alkalinization were provided to manage rhabdomyolysis.
Conclusion:
Positive evolution with discharge after ten days. Few reported cases of rhabdomyolysis are associated with MIS-C and none with such high CK values. Based on the possible complications, performing CK dosing in all patients with MIS-C is suggested routinely.
Palabras clave : Rhabdomyolysis; SARS-CoV-2; Multisystem Inflammatory Syndrome in Children (MIS-C); Renal Insufficiency.
